Mitch Leslie in Science:
When the diabetes treatments known as GLP-1 analogs reached the market in 2005, doctors advised patients taking the drugs that they might lose a small amount of weight. Talk about an understatement. Obese people can drop more than 15% of their body weight, studies have found, and two of the medications are now approved by the U.S. Food and Drug Administration (FDA) for weight reduction. A surge in demand for the drugs as slimming treatments has led to shortages. “This class of drugs is exploding in popularity,” says clinical psychologist Joseph Schacht of the University of Colorado School of Medicine.
But patient reports and animal studies have yielded tantalizing signs that the drugs may spur another unexpected and welcome effect: fighting addiction. Most early trials were disappointing, but they used less potent versions of the drugs. Now, at least nine phase 2 clinical trials are underway or being planned to test whether the more powerful compound semaglutide and its chemical cousins can help patients curb their use of cigarettes, alcohol, opioids, or cocaine. Hopes are high. Semaglutide (sold under the trade names Wegovy, Ozempic, and Rybelsus) “is truly the most exciting drug for the last few decades,” says neuropharmacologist Leandro Vendruscolo of the U.S. National Institute on Drug Abuse.
If the results of the new trials are positive, addiction science could have its own “Prozac moment,” says clinical neuroscientist W. Kyle Simmons of the Oklahoma State University Center for Health Sciences. In the 1980s, that drug brought a sea change to psychiatry, becoming part of popular culture and leading to the wider use of antidepressants.
More here.

In 1995, there weren’t many foreign tourists in the country. It was a year after the United States normalized relations with Hanoi and lifted sanctions. Most of the passengers on the flight to Hồ Chí Minh City were Việt kiều, visiting their country for the first time since they left. The tension they felt as they cleared customs was obvious.
In Germany they joke that Slavs live in poverty so they can drive home in a Mercedes. I hadn’t heard this stereotype growing up in so-called Australia. From there, we had to fly.
Sometimes words explode. It is a safe bet that, before 2022, you had never even heard the term ‘polycrisis’. Now, there is a very good chance you have run into it; and, if you are engaged in environmental, economic or security issues, you most likely have – you might even have become frustrated with it. First virtually nobody was using polycrisis talk, and suddenly everyone seems
Hiding in plain sight, the largely unexamined crack epidemic of the 1980s and early 1990s has much to teach us about current US drug policy, the blatant racism of drug-related sentencing, and the power of community action. In his important, balanced book
The tiny forest lives atop an old landfill in the city of Cambridge, Mass. Though it is still a baby, it’s already acting quite a bit older than its actual age, which is just shy of 2. Its aspens are growing at twice the speed normally expected, with fragrant sumac and tulip trees racing to catch up. It has absorbed storm water without washing out, suppressed many weeds and stayed lush throughout last year’s drought. The little forest managed all this because of its enriched soil and density, and despite its diminutive size: 1,400 native shrubs and saplings, thriving in an area roughly the size of a basketball court.

Advait Arun in Phenomenal World:
Greg Conti in Compact Magazine:
Jodi Dean in LA Review of Books:
D
Two pages into his new biography of Harry Smith, the enigmatic anthropologist, underground filmmaker, painter and music collector responsible for the influential “